| Rank | Title | Journal | Year | PubWeight™‹?› |
|---|---|---|---|---|
| 1 | APOBEC signature mutation generates an oncogenic enhancer that drives LMO1 expression in T-ALL. | Leukemia | 2017 | 0.77 |
| 2 | HSP90 inhibition leads to degradation of the TYK2 kinase and apoptotic cell death in T-cell acute lymphoblastic leukemia. | Leukemia | 2015 | 0.76 |
| 3 | TRIB2 reinforces the oncogenic transcriptional program controlled by the TAL1 complex in T-cell acute lymphoblastic leukemia. | Leukemia | 2015 | 0.76 |
| 4 | Aberrant activation of the GIMAP enhancer by oncogenic transcription factors in T-cell acute lymphoblastic leukemia. | Leukemia | 2016 | 0.75 |